The Board denied the Veteran's claims of service connection for blindness in the right eye, periorbital cellulitis and abscess, MRSA, and respiratory acidosis. The conditions are diseases that first manifested during a period of inactive duty for training (INACDUTRA) and were not as a result of an injury.
The deciding factor: The Board found no evidence of injuries or diagnoses related to the claimed disabilities during active service, and thus denied service connection based on INACDUTRA.
- Claimed conditions
- blindness in the right eye, periorbital cellulitis and abscess, methicillin resistant staphylococcus aureus (MRSA), respiratory acidosis
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 23, 2019
- Citation
- 19105293
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied the Veteran's claim for compensation under 38 U.S.C. § 1151 for a blind right eye disability, finding that the additional disability was not due to carelessness, negligence, lack of proper skill, error in judgment, or similar instance of fault on the part of VA, nor was it an event not reasonably foreseeable.
- Denied
The Board denied the Veteran's claim to reopen his service connection for blindness in the right eye and blurred vision, finding that new evidence did not raise a reasonable possibility of substantiating the claim.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.